Robert E. Stratford
School of Pharmacy
United States of America
Dr. Stratford received his Ph.D. in Pharmaceutical Sciences from the University of Southern California in 1987, working under the guidance of Professor Vincent Lee. His work was in the area of topical ocular delivery of peptide drugs, specifically characterizing enzymatic barriers in the cornea and conjunctiva. After completing his degree, Dr. Stratford joined the Pharmaceutical Sciences Division at Eli Lilly and Company in Indianapolis, Indiana. His research work there centered on developing and applying the Caco-2 model of intestinal absorption to support structure-absorption relationship studies for several chemical scaffolds encompassing neuroscience, cardiovascular, diabetes and infectious disease therapeutic initiatives.
Pharmacokinetic sources of intersubject variability, particularly regarding the intestinal and blood brain barrier absorption of drugs.
Purdy RE, Ashbrrok DW, Hurlbut DE, Reidy JP, Stratford RE, Watanabe MY. 1981. Effects of Reserpinization, Surgical Denervation with 6-Hydroxydopamine on the Contractile Response of Isolated Rabbit Ear Artery to Propranolol. Blood Vessels 18:153-160.
Ashbrook DW, Purdy RE, Hurlbut DE, Rains LA, Reidy JP, Stratford RE. 1980. A Novel Response to Propranolol: Contractile Response in the Isolated Rabbit Ear Artery. Life Sci. 26:155-163.